Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

5.00
Delayed Data
As of Feb 21
 +0.09 / +1.83%
Today’s Change
4.01
Today|||52-Week Range
8.38
+7.53%
Year-to-Date

Today’s Trading

Previous close4.91
Today’s open4.90
Day’s range4.90 - 5.07
Volume1,261,340
Average volume (3 months)1,831,021
Market cap$596.1M
Data as of 4:00pm ET, 02/21/2018

Growth & Valuation

Earnings growth (last year)+5.92%
Earnings growth (this year)--
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+89.60%
P/E ratioNM
Price/Sales8.78
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PTCTPTC Therapeutics Inc+0.87+3.60%
TGTXTG Therapeutics Inc+1.25+9.92%
BYSIBeyondspring Inc+0.11+0.40%
EGRXEagle Pharmaceutical...+0.50+0.79%
Data as of 4:00pm ET, 02/21/2018

Financials

Last reporting dateFebruary 7, 2018
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$60.6M
Annual profit (last year)-$163.4M
Net profit margin-269.52%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gregory P. Madison
Chief Operating Officer &
Senior Vice President
Christine A. Carberry
Corporate headquarters
Boston, Massachusetts

Forecasts